Refresh

Vivanza Biosciences Ltd. - Research Center

530057 VIVANZA Group (XT) BSE data
Back to Company

Results

Statement

More

Profit & Loss Account
(Rs crore)
Mar ' 24 Mar ' 23 Mar ' 22 Mar ' 21 Mar ' 20
Income

Operating income

14.41 14.21 9.15 9.22 9.43
Expenses

Material consumed

12.98 12.96 8.48 8.56 9.14

Manufacturing expenses

- - - - 0.02

Personnel expenses

0.31 0.26 0.12 0.29 0.26

Selling expenses

- - - - -

Adminstrative expenses

0.32 0.26 0.49 0.24 0.32

Expenses capitalised

- - - - -

Cost of sales

13.61 13.49 9.10 9.10 9.73

Operating profit

0.80 0.72 0.05 0.13 -0.30

Other recurring income

0.05 0.39 0.83 0.50 0.53

Adjusted PBDIT

0.85 1.11 0.88 0.63 0.23

Financial expenses

0.41 0.42 0.41 0.47 0.44

Depreciation

0.01 - 0.01 0.01 -

Other write offs

- - - - -

Adjusted PBT

0.43 0.69 0.46 0.15 -0.20

Tax charges

0.11 0.12 - 0.05 -

Adjusted PAT

0.32 0.57 0.46 0.10 -

Non recurring items

- - - - -

Other non cash adjustments

- - - - -

Reported net profit

0.32 0.57 0.46 0.10 -0.20

Earnigs before appropriation

0.72 0.40 -0.17 -0.63 -0.73

Equity dividend

- - - - -

Preference dividend

- - - - -

Dividend tax

- - - - -

Retained earnings

0.72 0.40 -0.17 -0.63 -0.73
Sectoral Indices Market Indicators Listed Companies Gainers Losers Mutual Funds Portfolio Watchlist
© 2024 Rediff.com